GW685698X

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaAllergic RhinitisSeasonal Allergic RhinitisVasomotor Rhinitis

1050 competitors in Asthma

#DrugCompanyPhaseTrials

1

GW685698X

GSK

Phase 3

72

Veramyst

GSK

Preclinical

463

Xolair

Roche

Preclinical

254

Singulair

AstraZeneca

Preclinical

175

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

356

Cinqair

Teva

Preclinical

137

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

308

Asmanex

Novartis

Preclinical

59

Celexa

AbbVie

Preclinical

110

Spiriva

Boehringer Ingelheim

Preclinical

8Show 25 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma7 trials

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

Completed·GSK·Phase 2·NCT00398645·648 enrolled

A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

Completed·GSK·Phase 2·NCT01499446·669 enrolled

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Completed·GSK·Phase 2·NCT00603382·599 enrolled

Show 4 more trials

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Completed·GSK·Phase 2·NCT00603746·627 enrolled

Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

Completed·GSK·Phase 1·NCT00444509·20 enrolled

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

Completed·GSK·Phase 2·NCT00603278·622 enrolled

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Completed·GSK·Phase 2·NCT00766090·190 enrolled

Allergic Rhinitis5 trials

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Completed·GSK·Phase 3·NCT00103454·288 enrolled

A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

Completed·GSK·Phase 3·NCT00116818·90 enrolled

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Completed·GSK·Phase 3·NCT00116883·90 enrolled

Show 2 more trials

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Completed·GSK·Phase 3·NCT00109486·56 enrolled

Perennial Allergic Rhinitis Study In Pediatric Subjects

Completed·GSK·Phase 3·NCT00108914·558 enrolled

Seasonal Allergic Rhinitis5 trials

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

Completed·GSK·Phase 3·NCT00118729·380 enrolled

Study of GW685698X In Patients With Seasonal Allergic Rhinitis

Completed·GSK·Phase 3·NCT00363740·38 enrolled

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

Completed·GSK·Phase 3·NCT00197262·288 enrolled

Show 2 more trials

Seasonal Allergic Rhinitis In Pediatric Subjects

Completed·GSK·Phase 3·NCT00107757·576 enrolled

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

Completed·GSK·Phase 3·NCT00225823·288 enrolled

Vasomotor Rhinitis2 trials

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis

Completed·GSK·Phase 3·NCT00118703·350 enrolled

Study Of Adults And Adolescents With Vasomotor Rhinitis

Completed·GSK·Phase 3·NCT00117325·352 enrolled

Drug1 trial

Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects

Completed·GSK·Phase 1·NCT00538057·16 enrolled

2 more indications

Function1 trial

Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function

Completed·GSK·Phase 1·NCT00419237·20 enrolled

Unspecified3 trials

Long Term Safety Of GW685698X Via Nasal Biopsy

Completed·GSK·Phase 3·NCT00224523·125 enrolled

Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers

Completed·GSK·Phase 1·NCT00522678·36 enrolled

A Study of GW685698X in Healthy Japanese Male Subjects

Completed·GSK·Phase 1·NCT00972673·48 enrolled

Details

Drug Info

Related News